Autres langues MeiraGTx Holdings plc

Actions

MGTX

KYG596651029

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/05/2024			Varia. 5j.	Varia. 1 janv.
5,53 ^USD	+5,74 %		+7,59 %	-21,23 %

15/05	Transcript : MeiraGTx Holdings plc Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM
09/05	MeiraGTx Holdings plc publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Earnings Flash (MGTX) MEIRAGTX Reports Q1 Revenue $697,000	09/05
MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
MeiraGTx Reports First Quarter 2024 Financial and Operational Results	09/05
MeiraGTx : Results of a Phase 1, Open-label, Dose-escalation Study of Gene Therapy with AAV2-hAQP1 as Treatment for Grade 2 and 3 Radiation-induced Late Xerostomia and Parotid Gland Hypofunction – The AQUAx Study	02/05
MeiraGTx to Participate in Upcoming Investor Conferences	24/04
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference	18/04
MeiraGTx Holdings plc Appoints Dr. Debra Yu to Serve on Each of the Compensation Committee and Science and Technology Committee of the Board	16/04
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates	14/03
MeiraGTx Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
North American Morning Briefing : Inflation Data -2-	12/03
Who are OpenAI's new board members?	11/03
MeiraGTx to Receive $50 Million Milestone Payment from J&J's Janssen Under Bota-Vec Deal	13/02
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	13/02
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	13/02
Progress In Preventing Blindness	26/01
Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors	03/01
MeiraGTx sells XLRP gene therapy to Janssen	22/12
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	21/12
Sector Update: Health Care Stocks Advance in Afternoon Trading	21/12
MeiraGTx Holdings Shares Rise on Sale of Remaining Bota-vec Interests to Janssen Pharmaceuticals for Up to $415 Million	21/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues MeiraGTx Holdings plc

Actions

MGTX

KYG596651029

Autres langues

Filtres